Star Imaging and Path Lab Limited has notified the stock exchanges of an upcoming Board of Directors meeting, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is scheduled to be held on Friday, 22nd May, 2026, at the registered office of the company.

Purpose of the Board Meeting

The primary agenda of the board meeting is to consider and approve the audited financial results of the company for the half year and financial year ended March 31, 2026. Both standalone and consolidated financial results are set to be reviewed at this meeting.

The key details of the scheduled board meeting are summarised below:

Trading Window Closure and Reopening

In continuation of the company's intimation letter dated Friday, 27th March, 2026, the trading window for dealing in the securities of the company was closed from Wednesday, 1st April, 2026, for all directors, Key Managerial Personnel (KMPs), designated persons, employees, connected persons, and their immediate relatives. This closure was made in accordance with the company's Internal Code of Conduct for Prohibition of Insider Trading, framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

The trading window shall reopen after the expiry of 48 hours from the date of declaration of the financial results at the board meeting.

Company Communication

The intimation was signed by Md Shadab Khan, Company Secretary and Compliance Officer (Membership Number: A74659), on 15th May, 2026. The company has also made this information available on its official website at www.starimaging.in . Star Imaging and Path Lab Limited was formerly known as Star Imaging and Path Lab Pvt. Ltd.

Star Imaging and Path Lab Limited has issued a clarification to BSE Limited regarding the recent significant movement in its share price, responding to the exchange's inquiry dated April 09, 2026. The company addressed concerns about price volatility through a formal communication on April 10, 2026.

Regulatory Compliance and Disclosure Status

The company confirmed its adherence to all regulatory disclosure requirements under SEBI LODR Regulations. Star Imaging and Path Lab Limited stated that all material information and events affecting the company's operations and performance have been regularly disclosed to the stock exchange in a timely and accurate manner.

The management emphasized compliance with principles governing disclosures and obligations outlined under Regulation 4 of the SEBI LODR Regulations and relevant circulars issued thereunder.

Price Movement Attribution

Star Imaging and Path Lab Limited clarified that no undisclosed material information or events exist that may influence the price or volume behavior of the company's securities. The company stated that all material facts and information have been properly disclosed and are available in the public domain on BSE Limited's website.

The management attributed the share price movement to market-driven factors, specifically citing general market conditions and speculative activities as the primary drivers. The company emphasized that management has no control over such price movements.

Insider Trading Compliance

The company disclosed that promoters, promoter group members, and key managerial personnel have not dealt in the company's securities in the recent past. This statement addresses potential concerns about insider trading activities that could influence share price behavior.

Commitment to Transparency

Star Imaging and Path Lab Limited reiterated its commitment to comply with SEBI LODR Regulations and assured continued prompt disclosure of any material information or price-sensitive events as required under Regulation 30. The communication was signed by Company Secretary and Compliance Officer Md Shadab Khan, who holds membership number A74659.